NFE2L2 and Hyperglycemia: In this study, we demonstrate that BA reverses hyperglycemia-mediated GLUT4 suppression in HASMCs and also partly reverses hyperglycemia-mediated eNOS suppression, Nrf2 suppression and NFκB p65 activation in HUVECs.